Published in Int J Radiat Oncol Biol Phys on September 01, 1998
Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons. Radiat Oncol (2011) 0.88
Definitive radiation therapy for early glottic cancer: experience of two fractionation schedules. Clin Exp Otorhinolaryngol (2012) 0.88
Adenylate kinase 3 sensitizes cells to cigarette smoke condensate vapor induced cisplatin resistance. PLoS One (2011) 0.87
Waiting time for radiation therapy in breast cancer patients in Quebec from 1992 to 1998: a study of surgically treated breast cancer patients in Quebec documents and helps to explain increased waiting times for radiation therapy. Healthc Policy (2006) 0.87
Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population. Strahlenther Onkol (2010) 0.87
Outcome of radiotherapy in T1 glottic carcinoma: a population-based study. Eur Arch Otorhinolaryngol (2008) 0.86
Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature. Rep Pract Oncol Radiother (2015) 0.83
Radiotherapy for T1a glottic cancer: the influence of smoking cessation and fractionation schedule of radiotherapy. Eur Arch Otorhinolaryngol (2013) 0.80
Short treatment time and excellent treatment outcome in accelerated hyperfractionated radiotherapy for T1 glottic cancer. Nagoya J Med Sci (2015) 0.75
Hypofractionated accelerated radiotherapy in T1-3 N0 cancer of the larynx: A prospective cohort study with historical controls. Rep Pract Oncol Radiother (2016) 0.75
The optimal radiotherapy schedule for T1 glottic cancers? Int J Radiat Oncol Biol Phys (1999) 0.75
Definitive radiation therapy for treatment of laryngeal carcinoma: impact of local relapse on outcome and implications for treatment strategies. Strahlenther Onkol (2013) 0.75
Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst (2000) 4.15
Gene interaction and single gene effects in colon tumour susceptibility in mice. Nat Genet (1996) 2.84
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol (2001) 2.28
Recombinant congenic strains--a new tool for analyzing genetic traits determined by more than one gene. Immunogenetics (1986) 2.28
Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology (1999) 2.24
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Pulmonary resection for metastases of colorectal origin. Chest (1995) 2.09
Is there a future for neutron capture therapy? Int J Radiat Oncol Biol Phys (1996) 2.08
Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. J Clin Oncol (1996) 1.95
Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr (1992) 1.89
Risk factors in breast-conservation therapy. J Clin Oncol (1994) 1.82
A decade of postlaryngectomy vocal rehabilitation in 318 patients: a single Institution's experience with consistent application of provox indwelling voice prostheses. Arch Otolaryngol Head Neck Surg (2000) 1.79
Target volumes in radiotherapy for high-grade malignant glioma of the brain. Radiother Oncol (2000) 1.76
Prognostic factors of neck node metastasis. Clin Otolaryngol Allied Sci (1982) 1.67
EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys (1995) 1.59
EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol (1995) 1.58
Insulin resistance and breast-cancer risk. Int J Cancer (1992) 1.57
Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer (1991) 1.56
Postmastectomy radiotherapy: questions for the twenty-first century. J Clin Oncol (1998) 1.55
Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann Surg Oncol (1999) 1.55
Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med (1993) 1.55
The interpretation of multiple P-values. Radiother Oncol (1994) 1.54
The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol (2000) 1.53
Lymph node metastasis from melanoma with an unknown primary site. Br J Surg (1990) 1.49
Clear cell sarcoma (malignant melanoma) of soft parts: A clinicopathologic study of 30 cases. Cancer (1999) 1.46
Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group. Radiother Oncol (2001) 1.43
The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach. Ann Oncol (1993) 1.42
Detection of systematic patient setup errors by portal film analysis. Radiother Oncol (1992) 1.41
Osteoid and bone formation in a nasal mucosal melanoma and its metastasis. Histopathology (1997) 1.41
Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies. Eur J Cancer (2005) 1.40
Profile of radiotherapy departments contributing to the Cooperative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys (1996) 1.40
Plea for a preoperative adjuvant approach in the management of rectal cancer. Int J Radiat Oncol Biol Phys (1994) 1.38
[Referred earache; an important symptom of head-and-neck cancers]. Ned Tijdschr Geneeskd (1998) 1.38
[Internal radiotherapy in prostatic carcinoma; disappointing long-term results of retropubic Iodine-125 implantation]. Ned Tijdschr Geneeskd (1996) 1.38
[A solitary sternal lesion found by skeletal scintigraphy following treatment for breast carcinoma]. Ned Tijdschr Geneeskd (2007) 1.38
[Radiotherapy of the neck as a risk factor for stroke]. Ned Tijdschr Geneeskd (2005) 1.38
The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report. Int J Radiat Oncol Biol Phys (1990) 1.37
Radiation-induced apoptosis. Cell Tissue Res (2000) 1.36
DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy. Int J Cancer (2000) 1.31
Psychological effects of breast conserving therapy in comparison with radical mastectomy. Int J Radiat Oncol Biol Phys (1985) 1.31
Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792). Eur J Cancer Clin Oncol (1989) 1.30
Age is not a limiting factor for radical radiotherapy in pelvic malignancies. Radiother Oncol (1997) 1.29
The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. Int J Radiat Oncol Biol Phys (1997) 1.26
Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin. Cancer Treat Rep (1984) 1.25
Resectable retroperitoneal soft tissue sarcomas. The effect of extent of resection and postoperative radiation therapy on local tumor control. Cancer (1994) 1.25
Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome. J Natl Cancer Inst (2001) 1.24
Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan. Surgery (1994) 1.23
Systematic approach to the treatment of chylous leakage after neck dissection. Head Neck (1996) 1.22
Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer (2003) 1.22
Some prognostic and epidemiologic factors in canine osteosarcoma. J Natl Cancer Inst (1979) 1.21
Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys (1999) 1.18
Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg (1997) 1.18
Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neurooncol (1993) 1.18
Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. Cancer Res (1999) 1.18
High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J Clin Oncol (2003) 1.17
Communication, functional disorders and lifestyle changes after total laryngectomy. Clin Otolaryngol Allied Sci (1994) 1.17
Does the combination of radiotherapy and debulking surgery favor survival in paranasal sinus carcinoma? Int J Radiat Oncol Biol Phys (2000) 1.13
Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations. Radiother Oncol (1988) 1.12
Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes. Genes Immun (2000) 1.12
The development of a prognostic score for patients with parotid carcinoma. Cancer (1999) 1.11
Determination of benzo[a]pyrene diol epoxide-DNA adducts in white blood cell DNA from coke-oven workers: the impact of smoking. J Natl Cancer Inst (1990) 1.11
Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours. J Neurol Neurosurg Psychiatry (1987) 1.10
Marfan syndrome in children and adolescents: predictive and prognostic value of aortic root growth for screening for aortic complications. Heart (1998) 1.10
Tamoxifen, serum lipoproteins and cardiovascular risk. Br J Cancer (1988) 1.08
Improvements in respiratory and psychosocial functioning following total laryngectomy by the use of a heat and moisture exchanger. Ann Otol Rhinol Laryngol (1993) 1.08
The H-reflex of the flexor carpi radialis muscle; a study in controls and radiation-induced brachial plexus lesions. J Neurol Neurosurg Psychiatry (1984) 1.08
The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys (1999) 1.08
Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes. Cancer (2000) 1.07
Marfan syndrome in children and adolescents: an adjusted nomogram for screening aortic root dilatation. Heart (1998) 1.07
Stage as major long term outcome predictor in minor salivary gland carcinoma. Cancer (2000) 1.07
Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer (1995) 1.06
Cancer of the esophagus and gastric cardia: recent advances. Dis Esophagus (2004) 1.06
The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother Oncol (1999) 1.05
Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma. Neurology (1983) 1.05
Osteosarcoma of the jaw bones. Long-term follow up of 48 cases. Int J Oral Maxillofac Surg (1997) 1.05
Evaluation of breast conserving therapy: clinical, methodological and psychosocial perspectives. Eur J Surg Oncol (1988) 1.04
Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration. Eur J Cancer Clin Oncol (1983) 1.04
Scc-1, a novel colon cancer susceptibility gene in the mouse: linkage to CD44 (Ly-24, Pgp-1) on chromosome 2. Oncogene (1992) 1.04
The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Res Treat (2008) 1.02
The simultaneous boost technique: the concept of relative normalized total dose. Radiother Oncol (1991) 1.02
The prevalence of mental health problems in Rwandan and Burundese refugee camps. Acta Psychiatr Scand (2000) 1.02
Primary lymphoma of mucosa associated lymphoid tissue (MALT) in the parotid gland. Clin Otolaryngol Allied Sci (1993) 1.02
Non-Hodgkin's lymphomata: clinical features in relation to histology. Br J Cancer Suppl (1975) 1.01
A verification procedure to improve patient set-up accuracy using portal images. Radiother Oncol (1993) 1.01